Since our last report in 2011, the market for computerized cognitive assessment, screening and testing has continued to expand. Key drivers for this market and growing technology product base include:
An Aging Global Population: 500 million people in the world today are older than 65. Dementia rates begin to rise sharply in this group after age 75.
Increased Awareness of Cognitive Health Issues: Rising rates of ADHD, Autism Spectrum Disorder, and sports concussions require standardized cognitive screening tools to help with diagnosis and treatment.
Advances in Technology Platforms: Portable cognitive screening is being enabled by tablet devices and internet access.
Over twelve companies and cognitive screening products are included in this report:
Representative companies and products include Cambridge Cognition (CANTABmobile), CNS Vital Signs, CogState (COGNIGRAM), HeadMinder, Medical Care Corp (MCI Screen), MedInteract (COGselftest), NeuroTrax (MindStreams), Psychology Software Tools (CAMCI), Screen Inc (CANS-MCI), Total Brain (WebNeuro), BrainFx, US Department of Defense, imPACT Applications.